3864 results for «613»

Filter By

3864 results

PCR e-Course 2020 Closing Ceremony: reinventing education in interventional cardiovascular medicine!

28 Jun 2020 – From PCR e-Course 2020

On behalf of the Core Team and the 271 e-Faculty members, Davide Capodanno, Jean Fajadet and William Wijns thank those who attended and participated in - as well as contributed to - PCR e-Course 2020. At a time when exchange with peers and extended networks like...

PCR e-Course 2020 Closing Ceremony:

Hotlines and innovations on left main & multivessel disease - PCR e-Course 2020

25 Jun 2020 – From PCR e-Course 2020

View a selection of hot lines from PCR e-Course 2020 on the topic of left main & multivessel disease:

  • One-year clinical outcomes of complex PCI treated with use of Ultimaster stent
  • Impact of residual SYNTAX score on all-cause death at 10 yrs in the SYNTAX trial
Hotlines and innovations on left main & multivessel disease

Hotlines and innovations on stents & scaffolds - PCR e-Course 2020

25 Jun 2020 – From PCR e-Course 2020

View a selection of hot lines from PCR e-Course 2020 on the topic of stents & scaffolds:

  • Advances in coronary stenting - Outcome of thinnest strut DES
  • TARGET All Comers Trial- three-year Results
  • Final results of the REMEDEE registry
  • e-ULTIMASTER registry: final results and differences across continents
  • Main results of the Biofreedom...
Hotlines and innovations on stents & scaffolds

Hotlines and innovations on peripheral interventions - PCR e-Course 2020

25 Jun 2020 – From PCR e-Course 2020

View a selection of hot lines from PCR e-Course 2020 on the topic of peripheral interventions:

  • Bariatric embolotherapy for obesity: a pilot single-blind sham-procedure RCT
  • Sirolimus-eluting balloon for vasculogenic erectile dysfunction
Hotlines and innovations on peripheral interventions

Hotlines and innovations on heart failure - PCR e-Course 2020

25 Jun 2020 – From PCR e-Course 2020

View a selection of hot lines from PCR e-Course 2020 on the topic of heart failure:

  • Pulmonary artery denervation: 12-month results of the TROPHY study
  • Clinical impact of revascularisation extension in Impella protected PCI
  • Phase-one results from the Venus HF - preCARDIA device trial
  • V-LAP system: first-in-human experience
  • Hybrid transcatheter left ventricular...
Hotlines and innovations on heart failure

Hotlines and innovations on stroke - PCR e-Course 2020

25 Jun 2020 – From PCR e-Course 2020

View a selection of hot lines from PCR e-Course 2020 on the topic of stroke:

  • The SIBERIA trial for carotid artery stenosis
  • A multicentre clinical study of LEFTEAR LAAC device
Hotlines and innovations on stroke

Aspirin vs. P2Y12 monotherapy in Onyx-1

26 Jun 2020 – From PCR e-Course 2020

Watch this session if you want to review the highlights of the Onyx ONE Month DAPT Program and to listen to commentary on the SAPT late breaker sub-analysis comparing the safety and efficacy of administering aspirin vs. P2Y12 inhibitor.

Videos included on this page: the Hot Line...

Aspirin vs. P2Y12 monotherapy in Onyx-1

Hotlines and innovations on other coronary interventions - PCR e-Course 2020

25 Jun 2020 – From PCR e-Course 2020

View a selection of hot lines from PCR e-Course 2020 on the topic of other coronary interventions:

  • Gender differences in outcomes after rational atherectomy PCI
  • Intensified antiplatelet therapy in post-PCI patients with HOPR
Hotlines and innovations on other coronary interventions - PCR e-Course 2020

Hotlines and innovations on valve interventions - PCR e-Course 2020

25 Jun 2020 – From PCR e-Course 2020

View a selection of hot lines from PCR e-Course 2020 on the topic of valve interventions:

  • Safety and efficacy of the TaurusOne TAVR system for aortic stenosis
  • Quantitative angiographic assessment of MR after mitral procedures
Hotlines and innovations on valve interventions - PCR e-Course 2020

Paclitaxel DCB for coronary lesions: 12-month results. Do drug-coated balloons PREVAIL?

25 Jun 2020 – From PCR e-Course 2020

Consult this abstract to discover the PREVAIL trial results and the implications for drug-coated balloons in percutaneous coronary intervention.

Videos included on this page: the abstract presentation and an Investigator Perspective.

Paclitaxel DEB for coronary lesions: 12-month results of the PREVAIL study

Hotlines and innovations on STEMI - PCR e-Course 2020

25 Jun 2020 – From PCR e-Course 2020

View a selection of hot lines from PCR e-Course 2020 on the topic of STEMI:

  • Stenosis Severity and Complete Revascularisation in STEMI
  • Analysis of changes in decision-making process during OCT-guided PCI
Hotlines and innovations on STEMI - PCR e-Course 2020

PICSO improves coronary microvascular function in patients with STEMI

25 Jun 2020 – From PCR e-Course 2020

Watch this video if you want to learn about the latest OxAMI-PiCSO study clinical results and to learn about the first-in-man of PiCSO in inferior STEMI patients.

Videos included on this page: the Hot Line presentation, an Investigator Perspective and a Wrap Up discussion.

Latest experience with PiCSO in STEMI patients

Update on the regulation of high-risk medical devices: a transatlantic perspective

25 Jun 2020 – From PCR e-Course 2020

Watch this session if you want to get an update on new developments in the regulation of high-risk medical devices in Europe and the USA and to learn about opportunities for physicians to become more involved in the regulatory environment.

This session was originally presented during PCR...

Update on the regulation of high-risk medical devices

PCR e-Course 2020 Hot lines: TAVI – part 2

26 Jun 2020 – From PCR e-Course 2020

Watch a series of Hot Lines on TAVI presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: PORTICO IDE, FlexNav Delivery System, FRANCE TAVI, BIVOLUT-X, VIVALL.

Hot lines: TAVI

Revascularisation strategies - PCR e-Course 2020 Hot lines

29 Jul 2020 – From PCR e-Course 2020

Watch a series of Hot Lines on revascularisation presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: ISIS II, REDUCER-I, RINCAL, SYNTAX score II 2020.

Revascularisation strategies

Left ventricular and systolic dimension determines anatomic suitability for transcatheter mitral valve implantation

25 Jun 2020 – From PCR e-Course 2020

A  common  exclusion  for  transcatheter  mitral  valve  implantation  (TMVI)  is  a  small  predicted  neo-left  ventricular  outflow  tract  (LVOT). Simulation of the neoLVOT is time-consuming, requires multi-detector computerised tomography (MDCT), specialised software, and computer models of the prosthesis. Measurements that do not require neoLVOT simulation may provide...

LVESD screening determines anatomic suitability for TMVI

CT guidance for coronary interventions - PCR e-Course 2020 Hot lines

26 Jun 2020 – From PCR e-Course 2020

Watch a series of Hot Lines on CT-guidance for PCI presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: CT-FFR CHINA, CAST-FFR, CT-QFR vs. myocardial perfusion imaging, CT-CTO trial, CCTA for optimal fluoroscopic coronary projections.

CT guidance for coronary interventions

New TMVI therapy to eliminate mitral regurgitation. Evidence and patient selection

26 Jun 2020 – From PCR e-Course 2020

Watch this video if you want to get the latest update on the first commercially available TMVI therapy (Tendyne), to learn about Tendyne clinical experience and how to identify the best candidates for this novel therapy.

New TMVI Therapy to eliminate mitral regurgitation: evidence and patient selection

PCR e-Course 2020 Late-Breaking Trials - part 2

26 Jun 2020 – From PCR e-Course 2020

Watch a series of Late-Breaking Trials presented during the PCR e-Course 2020 and see how they might have an impact on your practice: 

  • 2-year safety of revascularisation deferral based on iFR or FFR
  • CABG and PCI in patients with CTO and multivessel disease
  • Routine revascularisation vs. medical therapy
PCR e-Course 2020 Late-Breaking Trials

Two-year outcomes of Tendyne Transcatheter Mitral Valve Implementation (TMVI) to treat symptomatic severe mitral regurgitation

Learn more about the 2-year outcomes of the first 100 patients treated as part of the Tendyne Expanded Clinical Study, and how the latest Tendyne clinical evidence may change the way the heart team treats mitral regurgitation.

Videos included on this page: the Hot Line presentation and...

Two-year outcomes of
Didn’t find what you were looking for?